Ionis Pharmaceuticals (IONS) Assets Average (2010 - 2026)

Ionis Pharmaceuticals' Assets Average history runs 17 years deep, the most recent figure standing at $3.5 billion for Q1 2026.

• In Q1 2026, Assets Average rose 19.89% year-over-year to $3.5 billion; the TTM figure through Mar 2026 stood at $3.5 billion (up 19.89% YoY), while the FY2025 annual figure was $3.3 billion, up 8.91% from the prior year.
• Assets Average was $3.5 billion for Q1 2026 at Ionis Pharmaceuticals, up from $3.3 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $3.5 billion in Q1 2026 to a low of $2.4 billion in Q3 2022.
• Historically, Assets Average has averaged $2.9 billion across 5 years, with a median of $2.9 billion in 2025.
• The sharpest annual moves came in 2023 and 2024: Assets Average advanced 21.05% in 2023, then decreased 6.85% in 2024.
• A 5-year view of Assets Average shows it stood at $2.5 billion in 2022, then gained by 19.54% to $3.0 billion in 2023, then gained by 2.71% to $3.0 billion in 2024, then advanced by 7.76% to $3.3 billion in 2025, then rose by 6.36% to $3.5 billion in 2026.
• The last three Assets Average figures came in at $3.5 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.